Invited commentary: predicting human pharmaceutical cancer risk.
Leblanc
B
B
NovoSafe, 6 Cité Lemercier, 75017 Paris, France. bernard.leblanc@novosafe.eu
D000818:Animals; D015197:Carcinogenicity Tests / Q000379:methods* / Q000592:standards; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000139:chemically induced*; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D011237:Predictive Value of Tests; D051381:Rats
D004364:Pharmaceutical Preparations